Respiratory syncytial virus

Nirsevimab FAQs

Saudi National immunization strategy for RSV prevention

Ensuring overall RSV prevention in every individual Dr. Alia Podcast

Kuwait taking the lead in RSV protection for all infants in the Middle east

Podcast Dr. Dana Hajan

Epidemiological Characteristics of RSV

RSV Burden in Jazan

Beyond High-Risk: Expanding RSV Protection for Newborns and Infants

Nirsevimab RWD Metanalysis

Nirsevimab Metanalysis Real world data

Real World Evidence Impact of universal immunization with Nirsevimab

Burden of Disease

RSV History

RSV

All Infant Protection

Nirsevimab : Clinical Experience

RSV Burden in Infants

Nirsevimab International Recommendation

Rattle

Saudi initiatives on Bronchiolitis Recommendations

The first choice of RSV prevention is Nirsevimab; alternatively, palivizumab is to be considered in case of unavailability of Nirsevimab.

Beyfortus in Action

Implementing Beyfortus successfully (FR)

2024 RSV International Congress - ESPID

Implementing Beyfortus successfully (US)

Beyfortus in Action ECMMID

Implementing Beyfortus successfully

Implementing Beyfortus successfully (ES)

Beyfortus®, an innovative immunization

2024 RSV International Congress ECMMID